A First-in-Class Calcium Channel Inhibitor for the Treatment of Advanced Metastatic Prostate Cancers Resistant to Next-Generation Antiandrogen Therapy (2025-2028)
Experts
Professor
Gregory Monteith
Professorial Research Fellow
School of Pharmacy and Pharmaceutical Sciences
Faculty of Health, Medicine and Behavioural Sciences
